173 related articles for article (PubMed ID: 34988968)
1. Clinical, histopathological and prognostic features of primary cutaneous acral CD8
Kempf W; Petrella T; Willemze R; Jansen P; Berti E; Santucci M; Geissinger E; Cerroni L; Maubec E; Battistella M; Goodlad J; Guenova E; Lappalainen K; Ranki A; Craig P; Calonje E; Martin B; Whittaker S; Oschlies I; Wehkamp U; Nicolay JP; Wobser M; Scarisbruck J; Pimpinelli N; Stadler R; Kerl French K; Quaglino P; Lin J; Chen L; Beer M; Emanuel P; Dalle S; Robson A
Br J Dermatol; 2022 May; 186(5):887-897. PubMed ID: 34988968
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous peripheral T-cell lymphomas, unspecified/NOS and rare subtypes: a heterogeneous group of challenging cutaneous lymphomas.
Kempf W; Rozati S; Kerl K; French LE; Dummer R
G Ital Dermatol Venereol; 2012 Dec; 147(6):553-62. PubMed ID: 23149701
[TBL] [Abstract][Full Text] [Related]
3. Extrafacial indolent CD8-positive cutaneous lymphoid proliferation with unusual symmetrical presentation involving both feet.
Wobser M; Petrella T; Kneitz H; Kerstan A; Goebeler M; Rosenwald A; Geissinger E
J Cutan Pathol; 2013 Nov; 40(11):955-61. PubMed ID: 24102688
[TBL] [Abstract][Full Text] [Related]
4. Indolent CD8+ primary cutaneous T-cell lymphoma involving the eyelid of an adolescent.
Minzenmayer AN; Taylor K; Housewright CD; Bicknell LM; Hendrick SJ; Tsai JH; Siref A
J Cutan Pathol; 2021 Dec; 48(12):1489-1492. PubMed ID: 34218462
[TBL] [Abstract][Full Text] [Related]
5. Primary Cutaneous Acral CD8
Hathuc VM; Hristov AC; Smith LB
Arch Pathol Lab Med; 2017 Nov; 141(11):1469-1475. PubMed ID: 29072952
[TBL] [Abstract][Full Text] [Related]
6. Primary Cutaneous CD8+ T-cell Lymphoma, an Indolent and Locally Aggressive Form Mimicking Paronychia.
Beggs SM; Friedman BJ; Kornreich D; Okon L; Alpdogan O; Shi W; Sahu J
Am J Dermatopathol; 2018 Apr; 40(4):e52-e56. PubMed ID: 28984695
[TBL] [Abstract][Full Text] [Related]
7. Indolent CD8-positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient.
Kluk J; Kai A; Koch D; Taibjee SM; O'Connor S; Persic M; Morris S; Whittaker S; Cerroni L; Kempf W; Petrella T; Robson A
J Cutan Pathol; 2016 Feb; 43(2):125-36. PubMed ID: 26423705
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases.
Wobser M; Reinartz T; Roth S; Goebeler M; Rosenwald A; Geissinger E
Oncol Ther; 2016; 4(2):199-210. PubMed ID: 28261650
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up and management of small and medium-sized CD4
Virmani P; Jawed S; Myskowski PL; Horwitz S; Skripnik Lucas A; Moskowitz A; Pulitzer M; Zain J; Rosen ST; Querfeld C
Int J Dermatol; 2016 Nov; 55(11):1248-1254. PubMed ID: 27369070
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder: A clinical and histologic retrospective cohort study.
Stephan C; Grossman ME; Magro CM
Clin Dermatol; 2023; 41(6):666-679. PubMed ID: 37716580
[TBL] [Abstract][Full Text] [Related]
11. Primary Cutaneous Acral CD8+ T-Cell Lymphoma-A Single Center Review of 3 Cases and Recent Literature Review.
Tjahjono LA; Davis MDP; Witzig TE; Comfere NI
Am J Dermatopathol; 2019 Sep; 41(9):644-648. PubMed ID: 31433793
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category.
Williams VL; Torres-Cabala CA; Duvic M
Am J Clin Dermatol; 2011 Dec; 12(6):389-401. PubMed ID: 21863906
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous acral CD8 positive T-cell lymphoma with extra-cutaneous involvement: A long-standing case with an unexpected progression.
Alberti-Violetti S; Fanoni D; Provasi M; Corti L; Venegoni L; Berti E
J Cutan Pathol; 2017 Nov; 44(11):964-968. PubMed ID: 28796362
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features.
Kempf W; Mitteldorf C; Battistella M; Willemze R; Cerroni L; Santucci M; Geissinger E; Jansen P; Vermeer MH; Marschalko M; Papadavid E; Piris MA; Ortiz-Romero PL; Novelli M; Paulli M; Quaglino P; Ranki A; Rodríguez Peralto JL; Wobser M; Auschra B; Robson A
J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):658-668. PubMed ID: 32997839
[TBL] [Abstract][Full Text] [Related]
15. Atypical BCL6/GATA3+ Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma: A Diagnostic Challenge.
Prieto-Torres L; Camacho-García D; Piris MÁ; Requena L; Rodríguez-Pinilla SM
Am J Dermatopathol; 2021 Feb; 43(2):137-140. PubMed ID: 32675470
[TBL] [Abstract][Full Text] [Related]
16. Solitary CD8-Positive Primary Cutaneous Peripheral T-Cell Lymphoma: A Question of Classification.
Rolim I; BakShi A; West E; Azurdia R; Kempf W; Robson A
Am J Dermatopathol; 2021 Sep; 43(9):e107-e110. PubMed ID: 33767068
[TBL] [Abstract][Full Text] [Related]
17. CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas.
Wobser M; Roth S; Reinartz T; Rosenwald A; Goebeler M; Geissinger E
Br J Dermatol; 2015 Jun; 172(6):1573-1580. PubMed ID: 25524664
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
19. [Cutaneous lymphomas: new entities and rare variants].
Kempf W; Mitteldorf C
Pathologe; 2015 Feb; 36(1):62-9. PubMed ID: 25589355
[TBL] [Abstract][Full Text] [Related]
20. Homozygous Loss of CDKN2 in Primary Cutaneous CD8(+) Lymphoma NOS.
Robson A; Costa Rosa J; Semkova K; Bakr F; Cabecadas J
Am J Dermatopathol; 2024 Mar; 46(3):147-152. PubMed ID: 38175704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
